Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › ascites

Ascites

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for ascites

7 trials tracked for ascites: 3 in phase 3 or 4.

7Trials tracked
3Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 2 Phase 3 1 Phase 2 2 Other / NA 2
  1. Phase 4 Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis Completed
  2. Phase 4 Tolvaptan for Ascites in Cirrhotic Patients Completed
  3. Phase 3 Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites Completed
  4. Phase 2 Treatment With Octreotide in Patients With Lymphangioleiomyomatosis Completed
  5. Phase 2 Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT Completed
  6. N/A Improving Performance of Paracentesis in Medical Residency Training Completed
Show 1 more trials
  1. N/A The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy. Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
FIPS AUC 0.821 outperforms MELD scores for 90-day mortality prediction in TIPS for ascites
Gastroenterology Meta-analysis
FIPS AUC 0.821 outperforms MELD scores for 90-day mortality prediction in TIPS for ascites New score outperforms MELD for predicting death after TIPS for bleeding
This meta-analysis of 5,180 patients undergoing TIPS for ascites or gastroesophageal bleeding compared MELD-based scores and the FIPS index …
A new scoring system called FIPS may better predict 90-day death risk after TIPS for bleeding than older MELD scores.
Jun 1, 2026
First-in-human study finds VS-01 generally well tolerated in decompensated cirrhosis with ascites
Gastroenterology Phase I
First-in-human study finds VS-01 generally well tolerated in decompensated cirrhosis with ascites Early safety study of VS-01 infusion in 12 patients with advanced liver disease
This phase 1b, open-label, non-randomized study in 12 patients with decompensated cirrhosis, ascites, and covert hepatic encephalopathy foun…
A new liver treatment called VS-01 was safe for patients with advanced disease, causing mostly mild stomach issues in an early study of 12 p…
Apr 9, 2026